Literature DB >> 18672103

Complex constitutional subtelomeric 1p36.3 deletion/duplication in a mentally retarded child with neonatal neuroblastoma.

Bertrand Isidor1, Martine Le Cunff, Michelle Boceno, Pierre Boisseau, Caroline Thomas, Jean-Marie Rival, Albert David, Cédric Le Caignec.   

Abstract

Monosomy 1p36 is one of the most frequent subtelomeric microdeletion syndromes characterized by distinct craniofacial features and developmental delay/mental retardation. Other common symptoms include hypotonia, seizures, brain abnormalities, visual, auditory and heart defects. Neuroblastoma is a rare feature since to our knowledge only two patients with "pure" 1p36 deletion have been described. We report on a child with developmental delay and facial dysmorphy who developed neuroblastoma at 1 month of age. No primary site outside of the liver could be demonstrated and the tumour regressed spontaneously. Standard karyotyping was normal while subtelomeric screening using Multiplex Ligation-dependent Probe Amplification (MLPA) method revealed a constitutional de novo subtelomeric 1p36 deletion. Subsequent Agilent 244K oligonucleotide array-based comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) analysis showed a complex 1p36.3 deletion/duplication rearrangement. Among the best candidate genes predisposing to the development of neuroblastoma located in 1p36, the AJAP1 gene is the only gene present in the duplication while CHD5, TNFRSF25 and CAMTA1 are located outside of the rearrangement. Therefore, a gene-dosage effect involving a gene located in the duplication including AJAP1 might explain the neuroblastoma observed in our patient. The rearrangement might equally interfere with the expression of a gene located outside of it (including CHD5 located 1Mb away from the rearrangement) playing a role in the tumorigenesis. In conclusion, this study illustrates the complexity of such rearrangement characterized by array CGH and strengthens that constitutional 1p36.3 rearrangement predisposes to the development of neuroblastoma.

Entities:  

Mesh:

Year:  2008        PMID: 18672103     DOI: 10.1016/j.ejmg.2008.06.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  8 in total

1.  Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

Authors:  Annalisa Pezzolo; Angela Rita Sementa; Margherita Lerone; Martina Morini; Marzia Ognibene; Raffaella Defferrari; Katia Mazzocco; Massimo Conte; Anna Rita Gigliotti; Alberto Garaventa; Vito Pistoia; Luigi Varesio
Journal:  Cancer Biol Ther       Date:  2017-04-12       Impact factor: 4.742

2.  1p36.32 rearrangements and the role of PI-PLC η2 in nervous tumours.

Authors:  Vincenza Rita Lo Vasco
Journal:  J Neurooncol       Date:  2010-09-29       Impact factor: 4.130

Review 3.  Genetic susceptibility to neuroblastoma.

Authors:  Vanessa P Tolbert; Grace E Coggins; John M Maris
Journal:  Curr Opin Genet Dev       Date:  2017-04-28       Impact factor: 5.578

Review 4.  Genetic susceptibility to neuroblastoma: current knowledge and future directions.

Authors:  Laura E Ritenour; Michael P Randall; Kristopher R Bosse; Sharon J Diskin
Journal:  Cell Tissue Res       Date:  2018-03-27       Impact factor: 5.249

5.  CHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genes.

Authors:  Rebecca Casaday Potts; Peisu Zhang; Andrea L Wurster; Patricia Precht; Mohamed R Mughal; William H Wood; Yonqing Zhang; Kevin G Becker; Mark P Mattson; Michael J Pazin
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

6.  Pianp deficiency links GABAB receptor signaling and hippocampal and cerebellar neuronal cell composition to autism-like behavior.

Authors:  Manuel Winkler; Siladitta Biswas; Stefan M Berger; Moritz Küchler; Laurens Preisendörfer; Myeongjeong Choo; Simon Früh; Pascal D Rem; Thomas Enkel; Bernd Arnold; Dorde Komljenovic; Carsten Sticht; Sergij Goerdt; Bernhard Bettler; Oliver von Bohlen Und Halbach; Dusan Bartsch; Cyrill Géraud
Journal:  Mol Psychiatry       Date:  2019-09-11       Impact factor: 15.992

7.  Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma.

Authors:  Elena A Afanasyeva; Moritz Gartlgruber; Tatsiana Ryl; Bieke Decaesteker; Geertrui Denecker; Gregor Mönke; Umut H Toprak; Andres Florez; Alica Torkov; Daniel Dreidax; Carl Herrmann; Konstantin Okonechnikov; Sara Ek; Ashwini Kumar Sharma; Vitaliya Sagulenko; Frank Speleman; Kai-Oliver Henrich; Frank Westermann
Journal:  Life Sci Alliance       Date:  2021-03-03

8.  Comparative deletion mapping at 1p31.3-p32.2 implies NFIA responsible for intellectual disability coupled with macrocephaly and the presence of several other genes for syndromic intellectual disability.

Authors:  Jonathan D J Labonne; Yiping Shen; Il-Keun Kong; Michael P Diamond; Lawrence C Layman; Hyung-Goo Kim
Journal:  Mol Cytogenet       Date:  2016-03-17       Impact factor: 2.009

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.